Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-09-05
2006-09-05
Devi, S. (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S069300, C435S071100, C424S234100, C424S256100, C424S184100
Reexamination Certificate
active
07101989
ABSTRACT:
DsrA is an outer membrane protein ofH. ducreyithat confers serum resistance to the bacteria. Isolated polynucleotides encoding the protein, end expression vectors and host cells encoding the same, are described. Also described is a mutantH. ducreyistrain that does not express DsrA. Vaccines againstH. ducreyiand methods of using the same are also described.
REFERENCES:
patent: 4302204 (1981-11-01), Wahl et al.
patent: 4358535 (1982-11-01), Falkow et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4486539 (1984-12-01), Ranki et al.
patent: 4550081 (1985-10-01), Stocker
patent: 4563419 (1986-01-01), Ranki et al.
patent: 4599308 (1986-07-01), Hamer et al.
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4745051 (1988-05-01), Smith et al.
patent: 4745057 (1988-05-01), Beckage et al.
patent: 4757006 (1988-07-01), Toole, Jr. et al.
patent: 4761371 (1988-08-01), Bell et al.
patent: 4789734 (1988-12-01), Pierschbacher
patent: 4868104 (1989-09-01), Kurn et al.
patent: 4877729 (1989-10-01), Clark et al.
patent: 4879224 (1989-11-01), Wallner et al.
patent: 4879236 (1989-11-01), Smith et al.
patent: 4912038 (1990-03-01), Schilling, Jr. et al.
patent: 4997373 (1991-03-01), Tanaka et al.
patent: 5023243 (1991-06-01), Tullis
patent: 5077393 (1991-12-01), Hayashi
patent: 5149797 (1992-09-01), Pederson et al.
patent: 5273884 (1993-12-01), Gale et al.
patent: 5389518 (1995-02-01), Steele et al.
patent: 5491129 (1996-02-01), Shaltiel
patent: 5601831 (1997-02-01), Green et al.
patent: 5721115 (1998-02-01), Krivan et al.
patent: 5770213 (1998-06-01), Zlotnick
patent: 5866132 (1999-02-01), Malcolm
patent: 5912234 (1999-06-01), Ruoslahti et al.
patent: 2004/0033585 (2004-02-01), McCormick et al.
patent: 0 036 776 (1981-09-01), None
patent: 0 073 657 (1990-12-01), None
Johansson et al. Infect. Immun. 70: 899-908, Feb. 2002 (abstract).
Lewis DA. AIDS Patient Care STDS 14: 19-36, Jan. 2000 (abstract).
Phillips AJ. J. Pharm. Pharmacol. 53: 1169-1174, 2001.
Cole et al, “B-122 Expression of dsrA is required for efficient attachment ofHaemophilus ducreyito keratinocytes” Abstract Only, American Society for Microbiology 100thGeneral Meeting, Los Angeles California May 21-25, 2000.
Skurnik et al., “Analysis of the yopA gene encoding the Yop1 virulence determinants ofYersiniaspp.” Molecular Microbiology, 3: 4, 5175-529 (1989).
Agrawal et al.; “Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligodeoxynucleotides”Proc. Natl. Acad. Sci. USA87 1401-1405 (1990).
Albritton et al.; “Biology ofHaemophilus ducreyi” Microbiological Reviews53:4 377-389 (1989).
Alfa et al.; “Use of Tissue Culture and Animal Models to Identify Virulence-Associated Traits ofHaemophilus dicreyi” Infection and Immunity63:5 1754-1761 (1995).
Al-Tawfiq et al.; “An Isogenic Hemoglobin Receptor-Deficient Mutant ofHaemophilus ducreyiIs Attenuated in the Human Model of Experimental Infection”The Journal of Infections Diseases181 1049-1054 (2000).
Apicella et al.; “Phenotypic Variation in Epitope Expression of theNeisseria gonorrhoeaeLipooligosaccharide”Infection and Immunity55:8 1755-1761 (1987).
Baker et al.; “Effects of oligo sequence and chemistry on the efficiency of oligoeoxyribonucleotide-mediated mRNA cleavage”Nucleic Acid Research18:12 3537-3543 (1990).
Blaser et al.; “Role of the S-Layer Proteins ofCampylobacter fetusin Serum-Resistance and Antigenic Variation: A Model of Bacterial Pathogenesis”The American Journal Of The Medical Sciences306:5 325-329 (1993).
Bolivar et al.; “Construction and Characterization of New Cloning Vehicles”Gene2 95-113 (1977).
Bozue et al.; “Facile construction of mutations inHaemophilus ducreyiusing lacZ as a counter-selectable marker”FEMS Microbiology Letters164 269-273 (1998).
Carson et al.; “Cloning and sequencing of aHaemophilus ducreyi fur homolog” Gene176 125-129 (1996).
Chang et al.; “Phenotypic expression inE.coliof a DNA sequence coding for mouse dihydrofolate reductase”Nature275 617-624 (1978).
Chen et al.; “Evaluation of Purified UspA fromMoraxella catarrhalisas a Vaccine in a Murine Model after Active Immunization”Infection and Immunity64:6 1900-1905 (1996).
Chen et al; “The Levels and Bactericidal Capacity of Antibodies Directed against the UspA1 and UspA2 Outer Membrane Proteins ofMoraxella(Branhamella)catarrhalisin Adults and Children”Infection and Immunity67:3 1310-1316 (1999).
Colbére-Garapin et al.; “A New Dominant Hybrid Selective Marker for Higher Eukaryotic Cells”J. Mol. Biol.150 1-14 (1981).
Cole et al.; “Human monoclonal antibodies”Molecular and Cellular Biochemistry62 109-120 (1984).
Corbeil; “Molecular Aspects of Some Virulence Factors ofHaemophilus somnus” Can. J. Vet. Res.54 S57-S62 (1990).
Cote et al.; “Generation of human monoclonal antibodies reactive with cellular antigens”Proc. Natl. Acad. Sci. USA80 2026-2030 1983).
Crowe; “Chapter 55—Infections of the Immune System” 697-711.
De Boer et al.; “The tac promoter: A functional hybrid derived from the trp and lac promoters”Proc. Natl. Acad. Sci.80 21-25 (1983).
Dixon et al.; “An Analysis of the Complete Nucleotide Sequence of theHaemophilus duoreylBroad-Host-Range Plasmid pLS88”Plasmid32 228-232 (1994).
Dutro et al.; “Prevalence of, Antibody Response to, and Immunity Induced byHaemophilus ducreyiHemolysin”Infection and Immunity67:7 3317-3328 (1999).
Elkins et al.; “Identification and Purification of a Conserved Heme-Regulated Hemoglobin-Binding Outer Membrane Protein fromHaemophilus ducreyi” Infection and Immunity63:4 1241-1245 (1995).
Elkins et al.; “Characterization of the hgbA Locus Encoding a Hemoglobin Receptor fromHaemophilus ducreyi” Infection and Immunity63:6 2194-2200 (1995).
Elkins; “Role of theHaemophilus ducreyiTon System in Internalization of Heme from Hemoglobin”Infection and Immunity66:1 151-160 (1998).
Elkins et al.; “Serum Resistance inHaemophilus ducreyiRequires Outer Membrane Protein DsrA”Infection and Immunity68:3 1608-1619 (2000).
Fiers et al.; “Complete nucleotide sequence of SV40 DNA”Nature273 113-119 (1978).
Furdon et al.; “Rnase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds”Nucleic Acids Research17:22 9193-9204 (1989).
Goeddel et al.; “Direct expression inEscherichia coliof a DNA sequence coding for human growth hormone”Nature281 544-548 (1979).
Goeddel et al.; “Synthesis of human fibroblast interferon byE. coli” Nucleic Acids Research8:18 4057-4074 (1980).
Greenblatt et al.; “Genital ulceration as a risk factor for human immunodeficiency virus infection”AIDS An International Bimonthly Journal2:1 47-50 (1988).
Grunstein et al.; “Colony hybridization: A method for the isolation of cloned DNAs that contain a specific gene”Proc. Nat. Acad. Sci USA72:10 3961-3965 (1975).
Hansen et al.; “Use of Electroporation To Construct Isogenic Mutants ofHaemophilus ducreyi” Journal of Bacteriology174:16 5442-5449 (1992).
Hartman; “Two dominant-acting selectable markers for gene transfer studies in mammalian cells”Proc. Natl. Acad. Sci. USA85 8047-8051 (1988).
Helminen et al.; “A Large, Antigenically Conserved Protein on the Surface ofMoraxella catarrhalisIs a Target for Protective Antibodies”The Journal of Infectious Diseases170 867-72 (1994).
Hess et al.; “Cooperation of Glycolytic Enzymes”Advances in Enzyme Regulation7 149-167 (1969).
Hiltke et al.; Cloning of a gene encoding a 28 kilodalton outer membrane protein ofHaemophilus ducreyiAbstract #B155;Amer. Soc. Microbiol.Las Vegas, Nevada (1994).
Hiltke et al.; “Characterization of a Novel Lipoprotein Expressed byHaemophilus ducreyi”
Devi S.
Myers Bigel Sibley & Sajovec P.A.
University of North Carolina at Chapel Hill
LandOfFree
DsrA protein and polynucleotides encoding the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DsrA protein and polynucleotides encoding the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DsrA protein and polynucleotides encoding the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3605660